Published in Transplantation on December 15, 1999
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood (2005) 3.65
Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J Immunol (2008) 1.27
High KIR diversity in Amerindians is maintained using few gene-content haplotypes. Immunogenetics (2006) 1.17
High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Immunogenetics (2007) 1.17
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biol Blood Marrow Transplant (2010) 1.14
KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families. Immunogenetics (2008) 1.10
Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 1.09
The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics (2010) 1.07
Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics (2006) 1.07
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics (2010) 1.04
Characterization of killer immunoglobulin-like receptor genetics and comprehensive genotyping by pyrosequencing in rhesus macaques. BMC Genomics (2011) 0.99
Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med (2001) 0.98
Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol (2007) 0.97
Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations. Immunogenetics (2008) 0.93
Nature of allelic sequence polymorphism at the KIR3DL3 locus. Immunogenetics (2006) 0.92
Genetics of graft-versus-host disease: the major histocompatibility complex. Blood Rev (2012) 0.90
KIR gene content diversity in four Iranian populations. Immunogenetics (2009) 0.90
Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med (2006) 0.88
Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3. Immunogenetics (2007) 0.86
Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations. Immunogenetics (2006) 0.86
Immunogenetic characteristics of patients with autoimmune gastritis. World J Gastroenterol (2010) 0.82
KIR gene content in amerindians indicates influence of demographic factors. PLoS One (2013) 0.82
An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts. Immunogenetics (2006) 0.81
Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore. Immunogenetics (2008) 0.81
Human migration, diversity and disease association: a convergent role of established and emerging DNA markers. Front Genet (2013) 0.76
Kir genes, killer cells and clinical transplantation. Transplantation (1999) 0.75
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing. Oncoimmunology (2015) 0.75
KIR repertory in patients with hematopoietic diseases and healthy family members. BMC Hematol (2016) 0.75
Monoclonal antibodies for analysis of the HLA system. Immunol Rev (1979) 6.63
Analysis of a successful immune response against hepatitis C virus. Immunity (1999) 6.31
Pictures of MHC restriction. Nature (1996) 6.04
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol (1979) 5.06
Human diversity in killer cell inhibitory receptor genes. Immunity (1997) 4.82
Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem (1990) 4.02
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity (1997) 3.84
On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol (1983) 3.57
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med (1995) 3.43
IMGT/HLA database--a sequence database for the human major histocompatibility complex. Tissue Antigens (2000) 3.41
Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today (1990) 3.38
Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol (1979) 3.27
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
HLA-A and B polymorphisms predate the divergence of humans and chimpanzees. Nature (1988) 3.21
Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol (1981) 3.01
Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature (1978) 2.93
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol (1998) 2.79
Immunology. Deconstructing the MHC. Nature (1992) 2.76
Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol (1982) 2.74
Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc Natl Acad Sci U S A (1976) 2.71
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med (1994) 2.59
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol (1980) 2.56
Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science (1995) 2.44
Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci U S A (1990) 2.37
Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods (1982) 2.35
Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation. J Biol Chem (1977) 2.30
The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol (1992) 2.27
Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature (1988) 2.25
IMGT/HLA Database--a sequence database for the human major histocompatibility complex. Nucleic Acids Res (2001) 2.17
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature (1990) 2.17
Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol (2001) 2.02
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites. Proc Natl Acad Sci U S A (1979) 1.94
Heavy chain of HLA-A and HLA-B antigens is conformationally labile: a possible role for beta 2-microglobulin. Proc Natl Acad Sci U S A (1979) 1.93
Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med (1993) 1.93
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity (2000) 1.92
Location and distribution of the light chains in clathrin trimers. Proc Natl Acad Sci U S A (1983) 1.90
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Clathrin light chains contain brain-specific insertion sequences and a region of homology with intermediate filaments. Nature (1987) 1.89
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Evolution of class-I MHC genes and proteins: from natural selection to thymic selection. Annu Rev Immunol (1990) 1.87
Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol (1997) 1.86
A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens (2011) 1.81
Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature (1992) 1.79
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci U S A (2000) 1.78
HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature (1988) 1.78
Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med (1985) 1.77
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature (1989) 1.76
CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity (1996) 1.75
Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen. J Exp Med (1976) 1.74
Species-specific evolution of MHC class I genes in the higher primates. Immunol Rev (2001) 1.67
Purification of papain-solubilized histocompatibility antigens from a cultured human lymphoblastoid line, RPMI 4265. J Biol Chem (1975) 1.66
Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med (1995) 1.63
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens (2003) 1.60
The enigma of the natural killer cell. Nature (1995) 1.59
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med (1990) 1.55
Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns. J Biol Chem (1979) 1.54
Exon shuffling in vivo can generate novel HLA class I molecules. EMBO J (1985) 1.54
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med (1992) 1.53
Conservation and diversity in families of coated vesicle adaptins. J Biol Chem (1990) 1.53
Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J Immunol (1997) 1.52
Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature (1987) 1.50
Direct binding of influenza peptides to class I HLA molecules. Nature (1989) 1.49
Monoclonal antibodies to HLA--DRw determinants. Tissue Antigens (1980) 1.49
The immunoglobulin-like structure of human histocompatibility antigens. Transplant Rev (1974) 1.48
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 1.47
Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med (1990) 1.46
Monoclonal antibodies prepared against Dictyostelium actin: characterization and interactions with actin. J Cell Biol (1984) 1.46
Uncoating protein (hsc70) binds a conformationally labile domain of clathrin light chain LCa to stimulate ATP hydrolysis. Cell (1990) 1.42
Ancient HLA genes from 7,500-year-old archaeological remains. Nature (1991) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Multiple sclerosis. The case of the wonky mouse. Nature (1991) 1.39
The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol (1986) 1.39
Comparison of class I MHC alleles in humans and apes. Immunol Rev (1990) 1.33
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
Monoclonal antibodies against seven sites on the head and tail of Dictyostelium myosin. J Cell Biol (1985) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
Arginine 45 is a major part of the antigenic determinant of human beta 2-microglobulin recognized by mouse monoclonal antibody BBM.1. J Biol Chem (1983) 1.31
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31
Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol (1995) 1.31
Site-specific inhibition of myosin-mediated motility in vitro by monoclonal antibodies. J Cell Biol (1985) 1.31
The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics (2000) 1.29
The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2. Biochem J (1983) 1.28
16(th) IHIW : review of HLA typing by NGS. Int J Immunogenet (2013) 1.27
Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J Immunol (1989) 1.27
HLA class I region sequences, 1998. Tissue Antigens (1998) 1.27
Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol (2001) 1.27
Distinguishing recombination and intragenic gene conversion by linkage disequilibrium patterns. Genet Res (2000) 1.26
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and -B genes. Proc Natl Acad Sci U S A (1991) 1.23
Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25. J Immunol (1987) 1.23